Navigation Links
Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets

Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market. //

The tentative approval was given for strengths of 10 mg, 20 mg, 40 mg and 80 mg, the company informed the Bombay Stock Exchange.

The company would market the drug through its US subsidiary Zydus Pharmaceuticals (USA) Inc, following patent expiry, it added.

The drug, which had branded sales of approximately 1.8 billion dollars in the US market during 2005, is a lipid lowering agent.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Zydus Cadila and Kopran in strategic alliance
2. Cadila gets US FDA approval for Promethazine tablets
3. Cadila to Commence Phase I Clinical Trials On ZYH2
4. Tentative inhaled steroids is worse for lung patients
5. Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
6. Lupin Gets Tentative Nod from FDA for Antidepressant Drug
7. Morepan to file new drug applications with the USFDA
8. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
9. Lupin Gets USFDA Approval For Quinapril Tablets
10. Ranbaxy Gets USFDA Nod For Simvastatin
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... Aliso Viejo, CA (PRWEB) , ... May 03, 2016 , ... ... use in Final Cut Pro X. Pixel Film Studios’ titles allow users to add ... animations and basic elements such as boxes, lines and accents. To add greater contrast, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Today at its Annual Technology ... D. Pulido, R.Ph., Co-Founder of NCPDP and member of the NCPDP Foundation Board ... IT Specialist, Office of the National Coordinator for Health Information Technology (ONC). NCPDP’s ...
(Date:5/3/2016)... ... ... For over 23 years, Doctors on Liens has committed to ... and therapists treating personal injury patients on a lien basis. With the recent addition ... in Santa Monica, Doctors on Liens is continuing that tradition. While the network ...
(Date:5/3/2016)... ... ... With the opioid epidemic now at the forefront, attention has shifted away from ... its misuse causes long-term consequences for all aspects of society, from the disastrous effects ... and older. In addition, there is the long term affects of chronic liver ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... today announced that it has been honored as one of the nation’s most ... 2016 InformationWeek Elite 100. Horizon received the recognition for technology achievements that have ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... SAN FRANCISCO , May 2, 2016 /PRNewswire/ ...  is expected to reach USD 11.1 billion by ... Grand View Research, Inc. Major drivers of the ... in therapeutic areas and government recommendations for periodic ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ...
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:4/29/2016)... PARIS , April 29, 2016 ... Jérôme Contamine, Directeur Financier ... la santé, publie ses résultats pour ... Financier du Groupe, Jérôme Contamine, commente ... Groupe et les perspectives pour le ...
Breaking Medicine Technology: